Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3001
Gartner
IT
$11.7B
| $11.7M | ﹤0.01% |
73,765
+6,162
| +9% | +$1.13M |
2025 Q1
4 quarters
|
|
3002
CALL
Diageo
DEO
$47.1B
| $11.7M | ﹤0.01% |
156,800
+73,900
| +89% | +$6.45M |
2016 Q2
39 quarters
|
|
3003
CALL
Eastman Chemical
EMN
$7.42B
| $11.7M | ﹤0.01% |
152,900
-68,400
| -31% | -$4.93M |
2013 Q2
51 quarters
|
|
3004
Ryman Hospitality Properties
RHP
$8.39B
| $11.7M | ﹤0.01% |
126,297
-1,354,866
| -91% | -$130M |
2017 Q4
33 quarters
|
|
3005
Paychex
PAYX
$35.2B
| $11.6M | ﹤0.01% |
126,454
-115,029
| -48% | -$11.4M |
2025 Q3
2 quarters
|
|
3006
CALL
International Flavors & Fragrances
IFF
$21B
| $11.6M | ﹤0.01% |
160,400
-14,800
| -8% | -$1.09M |
2013 Q2
51 quarters
|
|
3007
PUT
Cboe Global Markets
CBOE
$28.3B
| $11.6M | ﹤0.01% |
41,400
-25,500
| -38% | -$7.1M |
2013 Q2
51 quarters
|
|
|
SKE
3008
CALL
Skeena Resources
SKE
$3.76B
| $11.6M | ﹤0.01% |
391,300
+355,700
| +999% | +$10.9M |
2023 Q3
10 quarters
|
|
3009
CALL
Warner Music
WMG
$14B
| $11.6M | ﹤0.01% |
455,300
+153,200
| +51% | +$4.34M |
2020 Q2
23 quarters
|
|
3010
Resideo Technologies
REZI
$2.79B
| $11.6M | ﹤0.01% |
344,946
+77,685
| +29% | +$2.77M |
2025 Q3
2 quarters
|
|
3011
CALL
Skyworks Solutions
SWKS
$12.8B
| $11.6M | ﹤0.01% |
217,000
+20,100
| +10% | +$1.17M |
2013 Q2
51 quarters
|
|
3012
WD-40
WDFC
$2.72B
| $11.6M | ﹤0.01% |
56,907
+49,942
| +717% | +$11.2M |
2017 Q1
36 quarters
|
|
3013
CALL
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$3.4B
| $11.6M | ﹤0.01% |
+477,600
| New | +$10.5M |
2026 Q1
0 quarters
|
|
3014
CALL
Vanguard High Dividend Yield ETF
VYM
$79.4B
| $11.6M | ﹤0.01% |
78,300
-7,700
| -9% | -$1.16M |
2019 Q4
25 quarters
|
|
3015
Azenta
AZTA
$1.7B
| $11.6M | ﹤0.01% |
548,364
+268,479
| +96% | +$8.02M |
2022 Q4
13 quarters
|
|
3016
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$363M
| $11.6M | ﹤0.01% |
108,600
-8,700
| -7% | -$940K |
2014 Q1
48 quarters
|
|
3017
CALL
Lumen
LUMN
$5.93B
| $11.6M | ﹤0.01% |
1,663,800
+126,900
| +8% | +$960K |
2013 Q2
51 quarters
|
|
3018
Takeda Pharmaceutical
TAK
$57.1B
| $11.6M | ﹤0.01% |
624,160
+234,426
| +60% | +$4.11M |
2025 Q3
2 quarters
|
|
3019
CALL
Builders FirstSource
BLDR
$6.05B
| $11.6M | ﹤0.01% |
140,400
+52,600
| +60% | +$5.62M |
2016 Q1
40 quarters
|
|
3020
Comstock Resources
CRK
$3.75B
| $11.5M | ﹤0.01% |
547,895
-145,925
| -21% | -$3.11M |
2023 Q3
10 quarters
|
|
|
CRNX
3021
DELISTED
Crinetics Pharmaceuticals
CRNX
| $11.5M | ﹤0.01% |
317,934
+63,214
| +25% | +$2.82M |
2022 Q3
14 quarters
|
|
3022
Reynolds Consumer Products
REYN
$4.7B
| $11.5M | ﹤0.01% |
544,896
+291,787
| +115% | +$6.69M |
2025 Q2
3 quarters
|
|
3023
PUT
MSCI
MSCI
$39B
| $11.5M | ﹤0.01% |
21,400
+2,500
| +13% | +$1.41M |
2017 Q1
36 quarters
|
|
3024
Avantis Responsible Emerging Markets Equity ETF
AVSE
$233M
| $11.5M | ﹤0.01% |
172,968
+105,275
| +156% | +$7.31M |
2025 Q1
4 quarters
|
|
|
ASTX
3025
PUT
Tradr 2X Long ASTS Daily ETF
ASTX
$228M
| $11.5M | ﹤0.01% |
316,300
+218,000
| +222% | +$12.6M |
2025 Q3
2 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.